|Articles|May 16, 2022

VIDA Introduces New AI-Enabled Biomarker Services

Suite of retrospective data analysis services for clinical trial sponsors created in response to growing demand for precision data in lung treatment trials.

VIDA Diagnostics, Inc. is introducing a new suite of retrospective data analysis services for clinical trial sponsors in response to growing demand for precision data to optimize lung treatment trials.

Read more about the new servces here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content